The product has not yet been released on the market.
Description
Pixera contains the active substance apixaban and belongs to a group of medicines called anticoagulants. This medicine helps to prevent blood clots from forming by blocking Factor Xa, which is an important component of blood clotting.
Indications
Pixera is used in adults:
- to prevent blood clots (deep vein thrombosis [DVT]) from forming after hip or knee replacement operations. (Only for Pixera 2.5 mg film-coated tablets)
- to prevent a blood clot from forming in the heart in patients with an irregular heart beat (atrial fibrillation) and at least one additional risk factor.
- to treat blood clots in the veins of your legs (deep vein thrombosis) and in the blood vessels of your lungs (pulmonary embolism), and to prevent blood clots from re occurring in the blood vessels of your legs and/or lungs.
Pixera is used in children aged 28 days to less than 18 years to treat blood clots and to prevent re-occurrence of blood clots in the veins or in the blood vessels of the lungs.
Subject to medical prescription.
Concentration and pharmaceutical form: 2.5 mg, 5 mg film-coated tablets
